“When we started looking at pharmacogenetics a few years ago, it was cutting-edge technology. I think more and more we are starting to see this as a standard of care,” said Dr. Joel Diamond.
Aranscia‘s Dr. Joel Diamond spoke with HIMSS TV to discuss the progression of precision medicine since his last interview at HIMSS 2022 and how molecular diagnostics is working to improve patient outcomes.
Click here to watch “Digital Checkup with Andrea Fox featuring Joel Diamond, MD, CMO at Aranscia.”
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
CloudFlare provides web performance and security solutions, enhancing site speed and protecting against threats.
Service URL: developers.cloudflare.com (opens in a new window)
These cookies are needed for adding comments on this website.
WPForms is a user-friendly WordPress plugin for creating custom forms with drag-and-drop functionality.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
